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Abstract
Purpose:  There  are  various  facial  pain  syndromes  including  trigeminal  neuralgia,  trigeminal
neuropathic  pain  and  atypical  facial  pain  syndromes.  Effectiveness  of  the  pulsed  radiofrequency
in managing  various  pain  syndromes  has  been  clearly  demonstrated.  There  are  a  limited  num-
ber of  studies  on  the  pulsed  radiofrequency  treatment  for  sphenopalatine  ganglion  in  patients
suffering  from  face  and  head  pain.  The  purpose  of  this  study  is  to  evaluate  the  satisfaction  of
pulsed radiofrequency  treatment  at  our  patients  retrospectively.
Methods:  Infrazygomatic  approach  was  used  for  the  pulsed  radiofrequency  of  the  sphenopala-
tine ganglion  under  ﬂuoroscopic  guidance.  After  the  tip  of  the  needle  reached  the  target  point,
0.25--0.5 ms  pulse  width  was  applied  for  sensory  stimulation  at  frequencies  from  50  Hz  to  1  V.
Paraesthesias  were  exposed  at  the  roof  of  the  nose  at  0.5--0.7  V.  To  rule  out  trigeminal  contact
that led  to  rhythmic  mandibular  contraction,  motor  stimulation  at  a  frequency  of  2  Hz  was
applied. Then,  four  cycles  of  pulsed  radiofrequency  lesioning  were  performed  for  120  s  at  a
temperature  of  42 ◦C.
Results:  Pain  relief  could  not  be  achieved  in  23%  of  the  patients  (unacceptable),  whereas
pain was  completely  relieved  in  35%  of  the  patients  (excellent)  and  mild  to  moderate  pain
relief could  be  achieved  in  42%  of  the  patients  (good)  through  sphenopalatine  ganglion-pulsed
radiofrequency  treatment.
Conclusion:  Pulsed  radiofrequency  of  the  sphenopalatine  ganglion  is  effective  in  treating  the
patients suffering  from  intractable  chronic  facial  and  head  pain  as  shown  by  our  ﬁndings.  There
is a  need  for  prospective,  randomized,  controlled  trials  in  order  to  conﬁrm  the  efﬁcacy  and
safety of  this  new  treatment  modality  in  chronic  head  and  face  pain.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights© 2014  Sociedade  Brasileir
reserved.∗ Corresponding author.
E-mail: akbasmert@akdeniz.edu.tr (M. Akbas).
ttp://dx.doi.org/10.1016/j.bjane.2014.06.001
104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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PALAVRAS-CHAVE
Gânglio
esfenopalatino;
Radiofrequência
pulsada;
Dor  crônica  facial  e
de  cabec¸a
Tratamento  com  radiofrequência  pulsada  para  gânglio  esfenopalatino  em  pacientes
com  dor  crônica  de  face  e  cabec¸a
Resumo
Objetivo:  Existem  várias  síndromes  de  dor  facial,  incluindo  neuralgia  trigeminal,  dor  neu-
ropática trigeminal  e  síndromes  atípicas  de  dor  facial.  A  eﬁcácia  da  radiofrequência  pulsada
(RFP) para  o  manejo  de  várias  síndromes  de  dor  foi  claramente  demonstrada.  Há  um  número  lim-
itado de  estudos  sobre  o  tratamento  com  RFP  para  gânglio  esfenopalatino  (GEP)  em  pacientes
que sofrem  de  dor  facial  e  de  cabec¸a.  O  objetivo  deste  estudo  foi  avaliar  a  satisfac¸ão  do
tratamento  com  PRF  em  nossos  pacientes,  retrospectivamente..
Métodos:  A  abordagem  infrazigomática  foi  usada  para  a  RFP  do  GEP  sob  orientac¸ão  ﬂuo-
roscópica. Depois  de  a  ponta  da  agulha  atingir  o  ponto  alvo,  pulsos  de  0,25  a  0,5  ms  foram
aplicados  para  a  estimulac¸ão  sensorial  em  frequências  de  50  Hz  a  1  V.  Parestesias  foram  expostas
no teto  do  nariz  em  0,5  a  0,7  V.  Para  excluir  o  contato  trigeminal  que  levou  à  contrac¸ão  mandibu-
lar rítmica,  a  estimulac¸ão  motora  foi  aplicada  na  frequência  de  2  Hz.  Em  seguida,  quatro  ciclos
de RFP  foram  realizados  durante  120  segundos  a  uma  temperatura  de  42 ◦C.
Resultados:  O  alívio  da  dor  não  foi  obtido  em  23%  dos  pacientes  (inaceitável);  enquanto  a  dor
foi totalmente  aliviada  em  35%  dos  pacientes  (excelente)  e  o  alívio  de  leve  a  moderado  da  dor
foi obtido  em  42%  dos  pacientes  (bom),  com  o  tratamento  RFP-GEP.
Conclusão:  RFP  para  GEP  é  eﬁcaz  no  tratamento  de  pacientes  que  sofrem  de  dor  crónica
intratável, facial  e  de  cabec¸a,  como  mostrado  por  nossas  descobertas.  Estudos  prospectivos,
randômicos  e  controlados  são  necessários  para  conﬁrmar  a  eﬁcácia  e  seguranc¸a dessa  nova
modalidade  de  tratamento  para  dor  crônica  facial  e  de  cabec¸a.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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The  etiologies  of  sphenopalatine  ganglion  (SPG)  neuralgia
include  irritation  of  the  ganglion  caused  by  intranasal  defor-
mities  such  as  deviated  septum,  septal  spurs,  and  prominent
turbinates.1 There  are  studies  reporting  the  use  of  SPG  block
to  relieve  various  pain  syndromes  such  as  post-traumatic
headache,  postherpetic  neuralgia,  myofascial  pain  involv-
ing  the  head-neck-shoulders,2 pain  due  to  tongue  cancer  and
cancer  of  the  ﬂoor  of  the  mouth,  atypical  odontalgia,  post-
temporomandibular  joint  (TMJ)  surgery,  angina,  back  pain,
sciatica  and  dysmenorrhea;  however,  many  of  these  reports
are  anectodal.  Therefore,  there  is  a  need  for  well-controlled
studies  on  the  above-mentioned  indications.  SPG  neural-
gia,  trigeminal  neuralgia  (TN),  migraine  headaches,  cluster
headaches,  postherpetic  neuralgia  and  atypical  facial  pain
are  currently  the  most  common  indications  for  SPG  block.3
Treatment  protocols  generally  begin  with  oral  med-
ications,  such  as  anticonvulsants,  nonsteroidal  anti-
inﬂammatory  drugs,  antidepressants  and  may  progress  to
invasive  procedures  such  as  percutaneous  or  open  surgical
procedures.  Carbamazepine  has  been  mainly  used  so  far  as
an  anticonvulsant  for  the  treatment  of  chronic  facial  and
head  pain1 although  its  efﬁcacy  decreases  in  time.2 Other
pharmacotherapies  such  as  pregabalin,  baclofen,  oxcar-
bazepine,  and  lamotrigine  have  been  used;  however,  they
do  not  seem  to  be  as  effective  as  carbamazepine.3 There-
fore,  invasive  treatments  such  as  neurosurgical  ablation  and
microvascular  decompression  are  needed.  The  success  rate
of  the  surgical  procedures  is  initially  as  high  as  98%,  whereas
h
phat  it  falls  down  to  80%  in  the  ﬁrst  1--2  years  and  to  64%  in
--10  years  as  shown  by  many  studies.4 Other  less  invasive
ptions  include  chemical  neurolysis  (such  as  glycerol  gan-
liolysis)  and  ablative  or  radiofrequency  (RF)  treatments.
adiofrequency  thermocoagulation  (RFTC)  is  a  minimally
nvasive  option  to  treat  chronic  facial  and  head  pain.  Follow-
ng  the  sensory  stimulation  of  nerves  in  awake  patients  under
uoroscopic  guidance,  thermal  lesion  is  performed  in  cycles
f  45--90  s  at  temperatures  of  60--90 ◦C.  The  reports  show
hat  the  success  rate  of  RFTC  is  83%,  while  the  recurrence
ate  is  49%  in  72  months.  Dysesthesia  has  been  observed  in
5%  of  the  cases  undergoing  this  treatment  modality.5
Pulsed  radiofrequency  (PRF)  has  been  increasingly  draw-
ng  attention  because  it  is  delivered  in  pulses;  thus  it  gives
ime  for  heat  and  energy  dissipation.  As  a  result,  surround-
ng  structures  are  less  damaged.6 Animal  studies  showed
istomorphological  changes  in  PRF  treated  sciatic  nerves
t  temperatures  of  40--80 ◦C  under  continuous  RF.  Studies
ound  that  changes  such  as  edema,  cell  and  myelin  patho-
ogical  changes  did  not  differ  signiﬁcantly  between  the  sham
nd  PRF  groups,  whereas  such  changes  were  signiﬁcantly
ifferent  in  the  continuous  RF  treatment  group.  Moreover,
ore  pathological  changes  were  observed  under  continuous
F  treatment  at  80 ◦C  in  contrast  to  40 ◦C.7 Although  PRF
as  been  successful,  multiple  interventional  therapies  are
eeded  for  a  successful  treatment  that  focuses  on  the  lives
f  patients.
The  purpose  of  this  study  is  to  evaluate  the  patients  who
ad  performed  PRF  to  SPG  because  of  chronic  face  and  head
ain  retrospectively.
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pigure  1  Patient  demographics  (sex)  undergoing  sphenopala-
ine  ganglion  pulsed  radiofrequency  treatment.
atients and  methods
7  patients  suffering  from  head  and  face  pain  (9  male  and  18
emale)  were  evaluated  underwent  PRF  treatment  for  SPG
rom  January  2010  to  December  2011  (Fig.  1).  The  study
rotocol  was  approved  by  the  medical  ethics  committee  of
ur  hospital  and  a  written  informed  consent  was  obtained
rom  each  patient.  PRF  was  performed  for  the  patients  to
anage  chronic  head  and  face  pain  caused  by  various  etiolo-
ies  such  as  atypical  facial  pain,  SPG  neuralgia  due  to  Zona
oster,  atypical  TN  that  did  not  respond  to  prior  treatments
nd  unilateral  migraine  headaches.  All  patients  responded
ositively  to  diagnostic  infrazygomatic  local  anesthetic  and
teroid  block.  The  same  pain  management  physician  exam-
ned  all  patients  and  reviewed  the  imaging  studies  before
he  injection.  We  used  the  patient  records  retrospectively
nd  clinical  follow-up  visits  prospectively  to  collect  data  at
n
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igure  3  (A)  Sphenopalatine  ganglion  pulsed  radiofrequency  trea
ulsed radiofrequency  treatment:  lateral  ﬂuoroscopic  imaging  of  thigure  2  Patient  demographics  (age)  undergoing  sphenopala-
ine  ganglion  pulsed  radiofrequency  treatment.
he  University  Faculty  of  Medicine,  Department  of  Anesthe-
iology,  Division  of  Algology.
The  age  of  our  patients  ranged  from  27  to  78  years,  with  a
ean  age  of  56  (Fig.  2).  Symptoms  were  present  for  3  months
o  30  years.  Infrazygomatic  approach  was  used  for  the  PRF  of
he  SPG  under  ﬂuoroscopic  guidance  (Fig.  3A).  Patients  were
ositioned  in  the  supine  position  on  the  ﬂuoroscopy  table.
ateral  view  was  obtained  at  mandibular  level  followed  by
he  rotation  of  the  head  under  continuous  ﬂuoroscopy  to
uperimpose  the  two  rami  of  the  mandible.  The  angle  of
he  C-arm  was  adjusted  toward  the  head  to  see  the  ptery-
opalatine  fossa  in  the  shape  of  an  ‘‘inverted  vase’’.  Local
nesthesia  was  administered  to  the  skin  and  underlying  tis-
ue  at  the  anterior  ramus  of  the  ipsilateral  mandible  below
he  zygoma.  To  facilitate  the  penetration  of  the  20-gauge
RF  needle,  a 16-gauge  angiocath  was  inserted  through  the
reviously  established  skin  entry  point.  Then,  advancement
f  a  10-cm  curved,  blunt  needle  with  a  10-mm  active  tip
as  realized  under  ﬂuoroscopy.  As  described  by  Raj  et  al.,8
he  needle  was  positioned  medially,  cephalad  and  slightly
osteriorly  toward  the  pterygopalatine  fossa  (Fig.  3B).  The
nterior--posterior  ﬂuoroscopic  imaging  conﬁrmed  that  the
eedle  lied  adjacent  to  the  lateral  nasal  mucosa  at  the
uperior-medial  angle  of  the  maxillary  sinus.8 After  the  tip
f  the  needle  reached  the  target  point,  0.25--0.5  ms  pulse
idth  was  applied  for  sensory  stimulation  at  frequencies
tment  in  pterygopalatine  nerve.  (B)  Sphenopalatine  ganglion
e  pterygopalatine  fossa  as  an  inverted  vase.
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Table  1  Satisfaction  Scale  after  3  months.
Unacceptable  7  (23%)
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Good  11  (42%)
from  50  Hz  to  1  V.9 Paraesthesias  were  exposed  at  the  roof
of  the  nose  at  0.5--0.7  V.  To  rule  out  trigeminal  contact  that
led  to  rhythmic  mandibular  contraction,  motor  stimulation
at  a  frequency  of  2  Hz  was  applied.  Then,  four  cycles  of  PRF
lesioning  were  performed  for  120  s  at  a  temperature  of  42 ◦C.
A  nurse  who  was  not  involved  in  the  procedures  asked  the
patients  to  rate  their  pain  on  Verbal  Numerical  Rating  Scale
(VNRS,  0--10)  in  3  months  after  the  procedure.
A  subjective  3-point  scale  that  was  designed  speciﬁcally
for  the  culture  of  each  patient  was  used  to  measure  and
understand  the  satisfaction  of  patients  about  the  pain  con-
trol  procedure  (unacceptable,  good,  excellent)  (Table  1).
Results
The  procedure  was  performed  on  the  left  side  in  sixty  per-
cent  of  the  patients  whereas  it  was  performed  on  the  right
side  in  29%  and  bilaterally  in  11%.
Pain  relief  could  not  be  achieved  in  23%  of  the  patients
(unacceptable)  (VNRS  7--10),  whereas  pain  was  completely
relieved  in  35%  of  the  patients  (excellent)  (VNRS  0--2)  and
mild  to  moderate  pain  relief  could  be  achieved  in  42%  of
the  patients  (good)  (VNRS  3--6)  through  SPG-PRF  treatment
(Fig.  1).  Neither  infection,  epistaxis,  hematoma,  dyses-
thesia,  numbness  of  the  palate,  maxilla  or  pharynx  nor
bradycardia  were  observed.
Mean  and  standard  deviations  in  anthropometric  and
demographic  data  were  given.  Friedmen  test  was  applied
for  VNRS  comparisons.  Wilcoxons  signed  rank  test  was
performed  with  Bonferroni  correction.  Signiﬁcance  was  con-
sidered  as  0.05.
Discussion
Chronic  face-head  pain  imposes  limitations  for  the  patients
and  affects  all  family  members.  Patients  present  with  anger
and  despair  when  they  visit  the  pain  clinic.  Therefore,  such
pain  should  be  managed  immediately  without  any  delay.
Percutaneous  SPG-PRF  treatment  of  head  and  facial  pain
was  demonstrated  to  be  surprisingly  lengthy  in  this  study.
In  Shah  study,10 SPG-pulsed  radiofrequency  lesioning  was
performed  on  the  patients  for  19  months  to  relieve  pain.
3  cycles  of  PRF  was  performed  in  that  study  while  we
performed  3  cycles.  We  had  to  repeat  the  procedure  on
the  involved  site  in  only  35%  of  our  patients.  No  adverse
effects  including  infection,  epistaxis,  hematoma,  dysesthe-
sia,  numbness  of  palate,  maxilla  or  pharynx  or  bradycardia
were  observed  in  our  study.  However,  unexpected  adverse
effects  were  reported  only  in  a  few  cases  during  RFTC  of  the
SPG  for  headache.11,12The  principle  of  radiofrequency  (RF)  is  that  it  is  in  the
form  of  alternating  electrical  current  and  the  heat  is  gen-
erated  around  the  tip  of  the  electrode.  Cell  culture  studies
have  shown  that  exposure  creates  a  biological  effect  due  to53
he  induction  of  early  gene  expression  in  the  dorsal  horn.13
FTC  has  been  used  to  destroy  the  tissue  in  TN,  ablate  tumor
etastasis,  perform  lateral  cordotomy  in  unilateral  malig-
ant  pain,  destroy  dorsal  root  ganglion  in  spinal  pain  and
reat  discogenic  back  pain.  But  RF  has  a  signal  output  which
s  typically  a  continuous  wave  of  RF  voltage,  whereas  PRF  has
 RF  wave  that  is  broken  into  short  bursts  of  signal  output.
etween  such  bursts,  there  are  some  time  periods  with  no
ignal.  There  is  often  no  need  to  increase  the  average  target
issue  temperature  above  42 ◦C  for  the  PRF  to  be  effective.14
Trigeminal  radiosurgery  has  been  recently  claimed  to  be
n  alternative  surgical  procedure  to  treat  chronic  cluster
eadache.15,16 However,  it  does  not  help  relieving  the  pain
n  a long-term  and  has  an  association  with  a  high  rate  of
oxicity.17,18
Combination  of  sphenopalatine  and  trigeminal  neurolytic
lock  was  reported  to  be  successful  in  a  case  study  to  relieve
acial  pain  due  to  a  tumor  that  caused  a  large  mid-facial
efect.19 Sphenopalatine  blocks  have  been  successfully  used
o  treat  cluster  headaches  that  typically  occur  in  the  peri-
rbital  region  as  described  by  the  patient.20
PRF  of  the  SPG  is  effective  in  treating  the  patients  suffer-
ng  from  intractable  chronic  facial  and  head  pain  as  shown  by
ur  ﬁndings.  But  we  must  remember  that  there  is  a  scarcity
f  studies  about  the  PRF  application  of  the  SPG  and  more
tudies  need  to  be  performed.  The  incidence  of  adverse
vents  may  be  reduced  because  the  needle  is  inserted  pre-
isely  to  the  target  point  under  the  real-time  ﬂuoroscopy
nd  electrical  stimulation  before  radiofrequency  lesioning.
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